An independent guide to cash-pay care. Every price is dated and sourced.

How we check
Wellchosen Health

Does insurance cover Zepbound or Mounjaro? What plans check

Zepbound and Mounjaro cost $25 to $1,112.16 a month depending on coverage, per Lilly's pages checked Oct 17, 2026 [3] [4] [16]. With commercial coverage, Lilly's savings cards can cut either to $25; without coverage Zepbound costs $299 to $449 a month on LillyDirect [5], and Mounjaro's list price is $1,112.16 [16]. Insurance pays only when your plan lists the drug for your diagnosis: Zepbound for weight management or sleep apnea with obesity, Mounjaro for type 2 diabetes [1] [2].

Updated Oct 17, 2026By the Wellchosen Health editorial team

Medical review: pending. A licensed clinician has not yet reviewed this page.

Zepbound and Mounjaro are the same drug, tirzepatide, under two FDA labels; insurance coverage follows the label, so Zepbound requests are judged on weight or sleep apnea criteria and Mounjaro requests on type 2 diabetes [1] [2].

Zepbound covered
As little as $25; savings up to $100 a month, $1,300 a year [3]
Mounjaro covered
As little as $25; savings up to $150 a month [4]
Plan does not cover Zepbound
KwikPen $299 to $449 with Lilly's card; LillyDirect $299 to $449 [3] [5]
Medicare
Zepbound KwikPen $50 a month under the GLP-1 Bridge [6]
Checked
Oct 17, 2026

Two labels, two sets of coverage rules

What a plan looks for with each tirzepatide brand
ZepboundMounjaroSource
Approved usesWeight management in adults with obesity, or overweight with a weight-related condition; moderate to severe sleep apnea with obesityBlood sugar control in type 2 diabetes (age 10+); heart risk reduction in high-risk adults with type 2 diabetes[1] [2]
BMI in the FDA approval30 or more, or 27 or more with a weight-related conditionNot a weight drug[7]
Savings card with coverage$25; up to 13 fills a year$25; up to 13 fills a year[3] [4]
Savings card without coverage$499 single-dose pen; KwikPen $299 to $449$499[3] [4]
Medicare GLP-1 BridgeKwikPen only, $50Not covered[6]
Lilly's savings cards exclude Medicare and Medicaid and end Dec 31, 2026 [3] [4]. More: Mounjaro vs Zepbound.

The four questions your plan asks

  1. Did your employer or plan include weight-loss drugs? Lilly cites survey data that about half of Americans with employer coverage lack coverage for obesity medicines [8]. If yours excludes them, a sleep apnea or diabetes diagnosis may still open a door.
  2. Is the drug on the formulary, and is another preferred? North Carolina Medicaid, for instance, covers Zepbound only after a Wegovy trial [9].
  3. Do you meet prior authorization criteria? Published examples mirror the label: TennCare's Aug 1, 2025 notice covers Zepbound with prior authorization for a BMI of 30 or more, or 27 or more with a related condition [10].
  4. Does the diagnosis match the brand? A Mounjaro request without type 2 diabetes is off-label, and Lilly's Mounjaro card requires an FDA-approved use [4].

Sleep apnea: the other route to Zepbound coverage

The FDA approved Zepbound for moderate to severe obstructive sleep apnea in adults with obesity on Dec 20, 2024 [11]. In the label's trials, apnea events fell by about half or more after a year [12]. Some plans that dropped weight-only coverage still cover sleep apnea: MassHealth covers adults with a BMI over 30 and moderate to severe sleep apnea [13], and Utah Medicaid keeps Zepbound for sleep apnea with prior authorization [14]. On Medicare, people with sleep apnea are excluded from the Bridge, and Medicare says their Part D plan might cover a GLP-1 [15]. Ask your plan whether the request needs a sleep study result.

Your cost with and without coverage

Zepbound and Mounjaro cost by coverage, checked Oct 17, 2026
SituationMonthly costNotesCheckedSource
Commercial plan covers ZepboundAs little as $251-, 2- or 3-month fill with the savings cardOct 17, 2026Lilly [3]
Commercial plan covers MounjaroAs little as $25Card savings up to $150 a monthOct 17, 2026Lilly [4]
Commercial plan does not cover ZepboundKwikPen $299 to $449; single-dose pen $499With the savings cardOct 17, 2026Lilly [3]
Commercial plan does not cover Mounjaro$499With the savings card; savings up to $647 a monthOct 17, 2026Lilly [4]
No insurance, Zepbound$299 to $449 on time; $499 to $699 lateLillyDirect self-payOct 17, 2026Lilly [5]
No insurance, Mounjaro$1,112.16List price; card not available to uninsured people. A LillyDirect cash price could not be confirmed.Oct 17, 2026Lilly [16] [4]
Medicare Part D, meets Bridge criteria$50Zepbound KwikPen onlyOct 17, 2026CMS [6]
See Zepbound cost, Mounjaro cost and the GLP-1 Price Tracker.

Getting it covered, including online

  1. Pull up your plan's formulary and look for Zepbound and Mounjaro, with any prior authorization or step therapy flags.
  2. Ask the plan what documents the request needs: BMI, related conditions, a sleep study, or diabetes labs.
  3. Have your prescriber submit it. Online programs that work with insurance can do this; LifeMD includes insurance help in its program fee [17], and Form Health takes insurance including Medicare [18].
  4. When approved, activate Lilly's savings card if you have commercial insurance [3].

If you are denied

  • Appeal with your prescriber. Check the denial letter for the reason and any appeal deadline; we could not confirm a standard deadline, so ask your plan and act quickly. Add any missing BMI, diagnosis or sleep study records.
  • Ask about the preferred drug. If the plan prefers Wegovy, see Wegovy insurance.
  • Use the uncovered-plan card. With commercial insurance that does not cover Zepbound, the KwikPen costs $299 to $449 with Lilly's card [3].
  • Pay cash. LillyDirect sells Zepbound at $299 to $449 when refilled within 45 days [5]. Compounded tirzepatide is cheaper but not FDA-approved [19]; read tirzepatide cost first.

Medicaid and tirzepatide

In January 2026, 13 state Medicaid programs covered GLP-1s for obesity [20]. Tennessee covered Zepbound with prior authorization under its Aug 1, 2025 notice [10], North Carolina covered it after a Wegovy trial when it reinstated coverage in December 2025 [9], and Michigan limits coverage to morbid obesity after other treatments fail [21]. Medi-Cal ended adult weight-loss coverage on Jan 1, 2026, but covers other uses when medically necessary [22]. We could not confirm changes after April 2026 outside Massachusetts and Utah. The full state table is on our Medicare and Medicaid page.

Tirzepatide safety, covered or not

Zepbound and Mounjaro carry a boxed warning for thyroid C-cell tumors seen in rats; do not use them with a personal or family history of medullary thyroid carcinoma or MEN 2 [12]. If stomach pain is severe and does not let up, or you notice signs of an allergic reaction, contact a clinician right away. Taking insulin or a sulfonylurea at the same time raises the chance of low blood sugar. Oral birth control may work less well for 4 weeks after starting and after each dose increase [2]. Stop Zepbound when pregnancy is recognized [12]. For an emergency, call 911.

We may earn a commission if you sign up through some links on this page. It never changes a verdict. How we make money

See Knownwell options

Programs that work with insurance (clean or caution only)

  1. Knownwell

    Clean
    Price
    Average $25 visit copay with insurance; no self-pay price published
    What you get
    Obesity medicine visits; prescribes Zepbound, Wegovy, Foundayo and others
    FDA record
    No FDA warning letter found as of Oct 17, 2026
    BBB
    Not yet checked
    Note
    No compounded drugs mentioned

    Visit Knownwell

  2. Form Health

    Clean
    Price
    $299 a month self-pay; insurance including Medicare accepted [18]
    What you get
    Clinician and dietitian visits; FDA-approved drugs only
    FDA record
    No FDA warning letter found as of Oct 17, 2026
    BBB
    Not yet checked
    Note
    HSA and FSA eligible

    Visit Form Health

  3. PlushCare weight loss

    Clean
    Price
    $19.99 membership; most insured visits $30 or less [23]
    What you get
    Zepbound and Wegovy for weight; Mounjaro for diabetes
    FDA record
    No FDA warning letter found as of Oct 17, 2026
    BBB
    Not yet checked
    Note
    Drugs and labs extra

    Visit PlushCare weight loss

Questions people ask

Does UnitedHealthcare, Anthem or Blue Cross cover Zepbound?

Coverage depends on your employer's plan, not the carrier name. One insurer runs many plans, and each employer chooses whether obesity drugs are included. To check: call the pharmacy number on your card, ask whether Zepbound is on your formulary for weight management or sleep apnea, ask what prior authorization needs, and ask your copay. If covered, Lilly's savings card can bring Zepbound to $25 [3].

Does Aetna, Cigna or BCBS cover Mounjaro?

Coverage depends on your employer's plan, not the carrier name. Ask your plan whether Mounjaro is on the formulary for type 2 diabetes and what prior authorization needs. Mounjaro is approved only for type 2 diabetes uses [2]. If covered, Lilly's card can bring the cost to $25 for a 1-, 2- or 3-month fill [4].

How do I get Zepbound covered by insurance?

Confirm Zepbound is on your plan's formulary, find out the prior authorization criteria, and have your prescriber submit records showing you meet them, such as a BMI of 30 or more, or 27 or more with a weight-related condition, matching the FDA approval [7], or moderate to severe sleep apnea with obesity [1]. Then use Lilly's savings card to bring the copay to as little as $25 [3].

How do I get Mounjaro covered without diabetes?

Mounjaro is approved only for type 2 diabetes uses [2], and Lilly's Mounjaro card requires an FDA-approved use [4]. Without diabetes, ask your plan about Zepbound, the same drug approved for weight management and sleep apnea [1].

Will insurance cover Zepbound or Mounjaro for sleep apnea?

Zepbound, yes, if your plan covers it for that use: the FDA approved it for moderate to severe sleep apnea in adults with obesity on Dec 20, 2024 [11]. Mounjaro is not approved for sleep apnea [2]. Some state Medicaid programs, such as MassHealth, still cover sleep apnea use after ending weight-only coverage [13].

How much is Zepbound or Mounjaro with insurance?

With a commercial plan that covers the drug, Lilly's savings cards can bring either to as little as $25 for a 1-, 2- or 3-month fill. Zepbound card savings are capped at $100 per month and Mounjaro at $150 [3] [4].

Does Medicare cover Zepbound?

For weight management, only the Zepbound KwikPen, at $50 a month under the GLP-1 Bridge for eligible Part D members through Dec 31, 2027 [6]. Mounjaro is not part of the Bridge [6].

Does GoodRx cover Mounjaro?

GoodRx is not insurance. Mounjaro's list price is $1,112.16 for 28 days [16], and Lilly's savings card applies only to commercially insured patients [4].

Will insurance cover tirzepatide for PCOS or prediabetes?

Neither is an approved use of Zepbound or Mounjaro [1] [2]. Coverage would depend on your plan accepting another qualifying reason, such as BMI criteria. On Medicare, prediabetes with a BMI of 27 or more qualifies for the Bridge, which covers the Zepbound KwikPen [15].

Sources

23 cited
  1. Zepbound (tirzepatide) label. DailyMed, National Library of Medicine, Aug 2026.
  2. Mounjaro (tirzepatide) label. DailyMed, National Library of Medicine, Aug 2026.
  3. Zepbound coverage and savings. Eli Lilly and Company, Oct 17, 2026.
  4. Mounjaro savings card terms. Eli Lilly and Company, Oct 17, 2026.
  5. Zepbound on LillyDirect: self-pay prices. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  6. Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, Oct 17, 2026.
  7. FDA approves new medication for chronic weight management. US Food and Drug Administration, Nov 8, 2023.
  8. Foundayo now available: Lilly's oral GLP-1 pill for weight loss. Eli Lilly and Company, Apr 9, 2026.
  9. NC Medicaid to reinstate coverage of GLP-1s for weight management. NC Department of Health and Human Services, Dec 19, 2025.
  10. TennCare provider notice: obesity management agents. OptumRx for TennCare, Aug 1, 2025.
  11. FDA approves first medication for obstructive sleep apnea. US Food and Drug Administration, Dec 20, 2024.
  12. Zepbound prescribing information (217806s050). US Food and Drug Administration, Apr 2026.
  13. MassHealth Pharmacy Facts 276. Commonwealth of Massachusetts, May 13, 2026.
  14. Utah Medicaid prior authorization: GLP-1 medications for weight-related comorbidities. Utah Department of Health and Human Services, Jun 1, 2026.
  15. Weight loss drugs coverage. Medicare.gov (CMS), Oct 17, 2026.
  16. Mounjaro frequently asked questions. Eli Lilly and Company, Oct 17, 2026.
  17. LifeMD weight management. LifeMD, Inc., Oct 17, 2026.
  18. Form Health FAQs. Form Health, Oct 17, 2026.
  19. FDA's concerns with unapproved GLP-1 drugs used for weight loss. US Food and Drug Administration, Oct 1, 2026.
  20. Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
  21. MDHHS Numbered Letter L 25-73: pharmacy. Michigan Department of Health and Human Services, Dec 8, 2025.
  22. Medi-Cal ends coverage of GLP-1s for weight loss. KFF Health News, Jan 9, 2026.
  23. PlushCare weight loss. PlushCare, Oct 17, 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

See Knownwell optionsWe may earn a commission